The level of vascular endothelial growth factor (VEGFA) at time of diagnosis is an independent prognostic factor for treatment outcome in multiple malignancies, including (paediatric) acute myeloid leukaemia (AML) (Aguayo et al, 1999; de Bont et al, 2002). This evidence concerns the gene VEGFA and acute myeloid leukemia.